CERETOX to present its R&D&I in toxicology potential at the UB-TECNIO Conference
The UB-TECNIO Conference on Food, Health Sciences and Industrial Systems is to be held at the Barcelona Science Park (PCB) on Tuesday 13 February. The event is organised by the Bosch i Gimpera Foundation (FBG) and will present UB Group TECNIO group and candidate technology to companies which have innovation and development requirements for new products and services. CERETOX is integrated by the PCB’s Experimental Toxicology and Ecotoxicology Technology Platform (UTOX) and the Toxicology Unit of the Faculty of Pharmacy of the University of Barcelona and will be one of the research centres to showcase its potential in R&D&I services for companies.
The event will be attended by the UB Group’s research groups, which have extensive and proven experience in working with companies, over 170 customers a year and more than €3 million in earnings. All of them either hold or are candidates for the TECNIO certification, which identifies the developers of the most innovative technologies for creating or enhancing new products or processes.
The TECNIO centres which are to take part include CERETOX, a centre consisting of the PCB’s Experimental Toxicology and Ecotoxicology Technology Platform (UTOX-PCB) and the Toxicology Unit of the Faculty of Pharmacy of the University of Barcelona. Today it is a leader in public and private sector toxicology research, innovation and services within the pharmaceutical, food, cosmetics, chemical, veterinary, healthcare and environmental management industries. Its lines of expertise range from conventional experimental toxicity studies to pharmacokinetics, ecotoxicology and nanotoxicology.
“In 2017 CERETOX promoted and consolidated a number of services for in vitro and in vivo experimental toxicology (histotechnology, clinical pathology and ADME/PK) and drawing up cosmetic safety reports,” says Àngel Menargues, Director of the Experimental Toxicology and Ecotoxicology Technology Platform UTOX-PCB / CERETOX-TECNIO. “The agreement we signed a few months ago with Methodex has enabled us to drive research into in vitro toxicology for cosmetics and also benefit from a gateway to related clinical trials. We are now putting the finishing touches to another three agreements designed to foster partnerships with companies and research centres so as to consolidate our extensive range of services for the healthcare, pharmaceutical and biotech industries.”
This year CERETOX has also begun conducting in vitro/in vivo ADMET screening and stepped up its analytics work with computer calculation and prediction tools in conjunction with the PCB’s Proteomics/Metabolomics Platform.
The UB-TECNIO conference is co-funded by ACCIÓ and is one of the many initiatives run by the Bosch i Gimpera Foundation, located at PCB, to join up universities, research and business and transfer innovation to society. The session will additionally feature a presentation of the SME Instrument, a European Commission programme that provides non-repayable grants to SMEs with innovative projects and high international growth potential, and a number of other Horizon 2020 programmes.
► Check the program [+info]
►Attendance is free of charge previous registration [+info]